Purpose To describe the content and potentials of the new Swedish national register on
prescribed and dispensed medicines. Methods The Swedish Prescribed Drug Register contains …

Background: Reduction in cardiovascular death and hospitalization for heart failure (HHF)
was recently reported with the sodium-glucose cotransporter-2 inhibitor (SGLT-2i) …

Aims Knowledge about stroke risk in paroxysmal atrial fibrillation (PxAF) is limited. Although
current guideline recommendations advocate the same treatment as in permanent atrial …

BACKGROUND: During the last decades substantial temporal changes, as well as population
differences, in coronary heart disease mortality have occurred in Sweden. There is little …

Background Randomized trials demonstrated a lower risk of cardiovascular (CV) events
with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D) …

STUDY OBJECTIVE: To examine associations between measures of work stress (that is, the
combination of high effort and low reward) and cardiovascular risk factors. DESIGN: Cross …

Background & Aims It is unclear whether the identification of individuals at risk of cirrhosis
using non-invasive tests can be improved by repeated measurements. Herein, we tested …

Aims Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely
manner according to evidence‐based clinical guidelines, is a key reason for uncontrolled …

Aims Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and
represents a major problem in clinical practice. To identify factors associated with warfarin …

Background & Aims Noninvasive scoring systems are used to identify persons with advanced
liver fibrosis. We investigated the ability of scoring systems to identify individuals in the …